Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 13, 2019

Total Value: $103M (100.0% shares, 0.0% debt)

Holdings (26)

AMARIN CORP PLC -ADR 18.2%
Value $18.79M Shares 1,239,568 Est. Cost $6.04 Unrealized
OXFORD IMMUNOTEC GLOBAL PLC 11.0%
Value $11.34M Shares 681,812 Est. Cost $16.13 Unrealized
BIODELIVERY SCIENCES INTL 10.6%
Value $10.93M Shares 2,595,855 Est. Cost $3.48 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 7.6%
Value $7.802M Shares 129,867 Est. Cost $82.07 Unrealized -9.5%
NEOS THERAPEUTICS INC 6.5%
Value $6.663M Shares 4,502,301 Est. Cost $1.82 Unrealized
CPIX CUMBERLAND PHARMACEUTICALS 5.0%
Value $5.102M Shares 860,449 Est. Cost $5.84 Unrealized -4.7%
APOLLO ENDOSURGERY INC 4.7%
Value $4.814M Shares 1,463,188 Est. Cost $4.60 Unrealized
OPIANT PHARMACEUTICALS INC 4.6%
Value $4.727M Shares 314,073 Est. Cost $16.03 Unrealized
XOMA XOMA CORP 4.4%
Value $4.537M Shares 230,201 Est. Cost $13.89 Unrealized +29.1%
IVERIC BIO INC 4.2%
Value $4.285M Shares 3,825,903 Est. Cost $1.30 Unrealized
HTG MOLECULAR DIAGNOSTICS 3.7%
Value $3.848M Shares 5,790,269 Est. Cost $1.63 Unrealized
ADAMAS PHARMACEUTICALS INC 3.7%
Value $3.841M Shares 751,012 Est. Cost $6.83 Unrealized
CTI BIOPHARMA CORP 3.0%
Value $3.107M Shares 3,711,999 Est. Cost $3.06 Unrealized
LGND LIGAND PHARMACEUTICALS 2.9%
Value $2.983M Shares 29,965 Est. Cost $75.54 Unrealized -16.9%
NOVELION THERAPEUTICS INC 2.6%
Value $2.685M Shares 3,703,420 Est. Cost $0.73 Unrealized
APTEVO THERAPEUTICS INC 1.9%
Value $2.008M Shares 3,413,421 Est. Cost $0.90 Unrealized
ALIMERA SCIENCES INC 1.5%
Value $1.552M Shares 2,740,417 Est. Cost $1.18 Unrealized
CORREVIO PHARMA CORP 1.0%
Value $1.019M Shares 509,356 Est. Cost $2.00 Unrealized
INTERPACE DIAGNOSTICS GROUP 0.9%
Value $922K Shares 1,160,378 Est. Cost $0.79 Unrealized
CHIASMA INC 0.5%
Value $543K Shares 109,743 Est. Cost $4.95 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 0.4%
Value $383K Shares 33,033 Est. Cost $16.16 Unrealized 0.0%
ACER THERAPEUTICS INC 0.4%
Value $364K Shares 114,175 Est. Cost $3.19 Unrealized
RETROPHIN INC 0.3%
Value $344K Shares 29,675 Est. Cost $11.59 Unrealized
AFFIMED NV 0.2%
Value $231K Shares 78,500 Est. Cost $3.04 Unrealized
DURECT CORPORATION 0.2%
Value $184K Shares 100,000 Est. Cost $1.84 Unrealized
DMAC DIAMEDICA THERAPEUTICS INC 0.0%
Value $28,000 Shares 13,705 Est. Cost $3.23 Unrealized 0.0%